Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
Not our test (this is the UK-RTC antibody test) but you can only assume surely that we will follow the same path.
http://www.med-technews.com/api/amp/news/ce-mark-for-covid-19-rapid-antibody-test-welcomed/
“ As part of its role within the consortium, Crumlin-based BBI Solutions’ patented smart based reader technology will guide users at home through performing a test before securely sharing the results directly with the NHS.”
Apologies if already posted. Suspect he is an Avacta LTH:
https://youtu.be/dOudW5KN1Z4
“Mologic my arse.”
Can I also just quote Sir Al:
“ The Affimer reagents that we have generated are very specific to SARS-CoV-2 antigen and we are confident of meeting and exceeding the clinical performance requirements for identifying the most infectious people.”
Have emailed HL and suggested they display this text anytime someone requests a quote to sell. :-)
This whole series of documents is interesting. Here is another, just out, covering higher education:
https://www.gov.uk/government/publications/principles-for-managing-sars-cov-2-transmission-associated-with-higher-education-3-september-2020
Clearly indicates this is a hot topic with lots of government brains working hard on it. Also suggests that a huge amount of logistical planning, policy setting and communication of the right messages will be required. Otherwise, compliance will be crappy.
I’m betting that Matt Handjob and BJ have done a massive pre-order with AVACTA based on preliminary performance data nobody else has seen. They need to be first in the queue and only money (in the form of a mega-order) talks. Sir Al isn't ramping up production based on a forecast from a salesman who drives a 1.8L Sierra Sapphire. He has a firm order (IMO).
This is a fantastic find Chiron, thanks.
A takeaway point for me is that specificity is far more important than sensitivity for mass population testing.
My reasoning is that lowish sensitivity can be addressed by increasing the frequency of the test. There may be a day or two delay in finding a case, thats all. It is easy to test more often where you have a simple pregnancy style test and other than the cost of more LFDs, it doesn’t draw on other NHS resources. It is a self-test after all.
If however the specificity is poor, the test could be churning out literally thousands of false positives a day. These are stressful and disruptive for the individuals involved (and the economy) and create a massive burden on PCR testing that is then required to sweep in and test the positive cases. You have to find out with are actually false. Increasing test frequency makes it even worse. Reducing frequency means you miss cases for longer. Its a lose lose situation.
Sir Al has stated that Affimers have excellent specificity.
Very happy to have the kitchen sink invested here.
The real PR requirement will be to convince the entire UK population to do the test once a week. Avacta wont be involved in this either. It will be UK Gov in full control, as it should be. Its a matter of public health.
If you only have one customer and you know they love the product already, why do you need PR? You don’t.
Think about it. If Avacta started any PR at this stage in proceedings what would happen?
1. Media would pounce on it and ask why not already in use.
2. Government get a beating.
3. Relationship between Avacta and Government (our biggest customer btw) damaged permanently.
4. Avacta product rushed out to try dissipate the media storm. Not good for anyone.
I also imagine their being an NDA in place and Sir Al is good to his word.
Just relax and wait. It is all coming.
“ don't you get the feeling that that statement would be followed by the following in a few days..."but the UK has managed to do it"(!) ?”
Han**** lines them up, BoJo knocks them down. Classic double act. A grand narrative of the heroism of the UK pharma industry and gov is being setup. BJ thinking of coming out of number 10 to Jerusalem playing at full tilt from Matt Handjobs car stereo, AVACTA LFD in hand.
This software role at Abingdon is interesting:
https://www.abingdonhealth.com/wp-content/uploads/2020/09/Software-Engineer-Positions-AppDx-Jun-2020.pdf
I can tell you from personal experience that is one hell of an ask from a single software engineer. Either they are a tad naive or are paying megabucks. Its a very nice shopping list though, someone knows their beans technically if not from a realistic recruitment perspective.
Very interesting the inclusion of GPS data. Presumably they plan to capture the location at which the LFD test has been performed. Could be useful for automated outbreak detection and for heat mapping.
“most infectious people” means this is an LFD with amazing sensitivity, not a PCR test. AS is also telling us we exceed the sensitivity requirement for a self test.
Its on!
A large number of posters, previously unknown to this board, have turned up of late. All tell tales of impending doom. Ask yourself how often you have spent hours debating with folks on a share board you have sold up from...
They want a cheap entry price now that life changing news is imminent. It must br ****ing them off royally just how well researched AVACTA shareholders are. Stick to your research findings people. The finishing line is in sight.
The louder they become, the more right I know I am.
Its a sign of an impending monster RNS.
More ****s = More profit
From August RNS:
“ We have been working with the Liverpool School of Tropical Medicine for some time to define the target performance specifications of the saliva-based rapid test and their insight has been tremendously helpful in this regard.”
Why would LSTM have input to target performance specifications?
Agree that a website wouldn't work. Results could be tracked securely using this:
https://bbisolutions.com/services/novarum-smartphone-reader.html
Could be being branded as ‘Saturn Pass’. See www.medusa19.com
I’m seeing this text appear in messages today and yesterday on this board. The paid de-rampers have realised they are going to need to be more subtle so are posing as concerned investors. What a bunch of covidiots. Green box for the lot of them. Job done.
This feels very feasible to me ZZ. If you are the project manager at Avacta getting the LFD to manufacture you’re not going to want the CONDOR evaluation in your critical path. Wheel in a quick but highly effective de-risking activity (LSTM) then push on with manufacture. Also keeps you in control, something all good PMs seek out constantly.
You may even be moving ahead with manufacture ‘at risk’ having characterised the level of any potential non-ideal LSTM result and decided the benefits outweighed them. Think of a game of football. Strikers constantly make runs at goal ‘at risk’ (they may not get the pass) and this gives the team an edge. We may very well be running 100% at manufacture as we speak, especially if confidence is high based on existing work.
Very pleased to see this board back to normal this morning. Everyone gets something different from it I’m sure. I enjoy getting tips on things to research. I enjoy the different characters, the banter and the in-jokes. I even enjoy when some posters go off on an eloquent ramp-fest. It is a bit of fun that reminds me of the upside we are all aspiring to. It balances my own natural tendency of being a bit ‘glass half empty’.
We are a nice community here. Lets keep it that way. If (when) the trolls, paid de-rampers and general wind up merchants arrive again how about this as a three stage plan:
1. Ignore them.
2. Never reply to them.
3. Block them if it helps.
Ironically, they have all the characteristics of a virus in their own right. They cannot survive without a host. Lets kill them off and get on with all things Avacta. Very important news is coming very soon now.
Is it just me or does this smell of BS?
https://mtrx5.com/
A telecoms company?